Rationale for a phase I/II radiation dose-escalation study with concurrent amifostine (ethyol) and infusional 5-FU chemotherapy for preoperative treatment of unresectable or locally recurrent rectal carcinoma

Robert Myerson

    Research output: Contribution to journalArticlepeer-review

    2 Scopus citations

    Fingerprint

    Dive into the research topics of 'Rationale for a phase I/II radiation dose-escalation study with concurrent amifostine (ethyol) and infusional 5-FU chemotherapy for preoperative treatment of unresectable or locally recurrent rectal carcinoma'. Together they form a unique fingerprint.

    Medicine & Life Sciences